These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29440770)

  • 21. In-vitro characterisation of a novel antimicrobial agent, TNP-2092, against Helicobacter pylori clinical isolates.
    Wang B; Zhao Q; Yin W; Yuan Y; Wang X; Wang YH; Wang H; Ye W; Chen S; Guo HL; Xie Y
    Swiss Med Wkly; 2018; 148():w14630. PubMed ID: 30044468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children].
    Chen J; Yu JD; Huang XL; Chen FB; Li ZY; Zhang XP
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):850-3. PubMed ID: 15631715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
    Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
    J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four N-(E)-cinnamoyl (cinnamamide) derivatives of aminoalkanols with promising anticonvulsant and analgesic activity.
    Gunia-Krzyżak A; Bareyre FM; Marona H; Waszkielewicz AM
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1298-1303. PubMed ID: 30975624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori.
    Weseler A; Geiss HK; Saller R; Reichling J
    Pharmazie; 2005 Jul; 60(7):498-502. PubMed ID: 16076074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
    Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
    Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
    Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
    Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
    BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and anti-Helicobacter pylori activity of pyloricidin derivatives II. The combination of amino acid residues in the dipeptidic moiety and its effect on the anti-Helicobacter pylori activity.
    Hasuoka A; Nishikimi Y; Nakayama Y; Kamiyama K; Nakao M; Miyagawa K; Nishimura O; Fujino M
    J Antibiot (Tokyo); 2002 May; 55(5):499-507. PubMed ID: 12139019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
    Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
    World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of aminoreductone against Helicobacter pylori.
    Trang VT; Takeuchi H; Kudo H; Aoki A; Katsuno S; Shimamura T; Sugiura T; Ukeda H
    J Agric Food Chem; 2009 Dec; 57(23):11343-8. PubMed ID: 19891477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Helicobacter pylori activity of Aristolochia paucinervis Pomel extracts.
    Gadhi CA; Benharref A; Jana M; Lozniewski A
    J Ethnopharmacol; 2001 May; 75(2-3):203-5. PubMed ID: 11297852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: A prevalence cross-sectional study in Spain.
    Macías-García F; Llovo-Taboada J; Díaz-López M; Bastón-Rey I; Domínguez-Muñoz JE
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28913872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
    Furuta T; Soya Y; Sugimoto M; Shirai N; Nakamura A; Kodaira C; Nishino M; Okuda M; Okimoto T; Murakami K; Fujioka T; Hishida A
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1810-5. PubMed ID: 17914955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori: in vitro induction of resistance to azithromycin.
    Kalenić S; Plecko V; Kresić S; Presecki V; Tripković V; Zele-Stracević L; Katicić M; Dominis M
    Chemotherapy; 1998; 44(1):17-20. PubMed ID: 9444404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori.
    Rong Q; Xu M; Dong Q; Zhang Y; Li Y; Ye G; Zhao L
    BMC Complement Altern Med; 2016 Aug; 16(1):331. PubMed ID: 27576439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel class of selective anti-Helicobacter pylori agents 2-oxo-2H-chromene-3-carboxamide derivatives.
    Chimenti F; Bizzarri B; Bolasco A; Secci D; Chimenti P; Carradori S; Granese A; Rivanera D; Lilli D; Zicari A; Scaltrito MM; Sisto F
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3065-71. PubMed ID: 17395462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
    Bogaerts P; Berhin C; Nizet H; Glupczynski Y
    Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationship study of a series of N-substituted piperazinyl-fluoroquinolones as anti-Helicobacter pylori agents.
    Foroumadi A; Safavi M; Emami S; Siavoshi F; Najjari S; Safari F; Shafiee A
    Med Chem; 2008 Sep; 4(5):498-502. PubMed ID: 18782047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori.
    Zaidi SF; Yamada K; Kadowaki M; Usmanghani K; Sugiyama T
    J Ethnopharmacol; 2009 Jan; 121(2):286-91. PubMed ID: 19041711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.